Correlation Between Anixa Biosciences and INmune Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anixa Biosciences and INmune Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anixa Biosciences and INmune Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anixa Biosciences and INmune Bio, you can compare the effects of market volatilities on Anixa Biosciences and INmune Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anixa Biosciences with a short position of INmune Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anixa Biosciences and INmune Bio.

Diversification Opportunities for Anixa Biosciences and INmune Bio

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Anixa and INmune is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Anixa Biosciences and INmune Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INmune Bio and Anixa Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anixa Biosciences are associated (or correlated) with INmune Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INmune Bio has no effect on the direction of Anixa Biosciences i.e., Anixa Biosciences and INmune Bio go up and down completely randomly.

Pair Corralation between Anixa Biosciences and INmune Bio

Given the investment horizon of 90 days Anixa Biosciences is expected to generate 2.53 times less return on investment than INmune Bio. But when comparing it to its historical volatility, Anixa Biosciences is 1.33 times less risky than INmune Bio. It trades about 0.21 of its potential returns per unit of risk. INmune Bio is currently generating about 0.39 of returns per unit of risk over similar time horizon. If you would invest  530.00  in INmune Bio on November 4, 2024 and sell it today you would earn a total of  392.00  from holding INmune Bio or generate 73.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Anixa Biosciences  vs.  INmune Bio

 Performance 
       Timeline  
Anixa Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anixa Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
INmune Bio 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in INmune Bio are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, INmune Bio sustained solid returns over the last few months and may actually be approaching a breakup point.

Anixa Biosciences and INmune Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anixa Biosciences and INmune Bio

The main advantage of trading using opposite Anixa Biosciences and INmune Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anixa Biosciences position performs unexpectedly, INmune Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INmune Bio will offset losses from the drop in INmune Bio's long position.
The idea behind Anixa Biosciences and INmune Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data